Tapewire

Nasdaq · USD

TMDX

TransMedics Group, Inc.

Export transactions ↓
Tapewire entity
4261
SEC CIK
0001756262
Parsed reports
356

Last 12 months

Inside the activity.

2 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202511
Dec 202502
Jan 202600
Feb 202600
Mar 202607
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 05, 2021 Filed Mar 9, 2021 17:36 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 5,452 $0.28 $1,526.56
Disclosure

SEC source: 0000899243-21-010701 · doc4.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,076

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 05, 2021 Filed Mar 9, 2021 17:36 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 14,548 $0.39 $5,673.72
Disclosure

SEC source: 0000899243-21-010701 · doc4.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 17:48 UTC
Khayal Tamer IChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-21-008448 · doc4.xml · derivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2031-02-24

F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:52 UTC
Hassanein Waleed HDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 310,000 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-21-008457 · doc4.xml · derivative · entry 1

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,000

Underlying: Common Stock · 310,000 shares

Expires 2031-02-24

F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:53 UTC
Gordon StephenChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-21-008458 · doc4.xml · derivative · entry 1

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2031-02-24

F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:49 UTC
Sullivan John FVP of Quality & Engineering
GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-21-008450 · doc4.xml · derivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2031-02-24

F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:51 UTC
Carey John FVP of Operations
GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-21-008456 · doc4.xml · derivative · entry 1

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2031-02-24

F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:45 UTC
Provost MiriamVP of US Regulatory & FDA Rel.
GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-21-008444 · doc4.xml · derivative · entry 1

Provost Miriam · CIK 0001773663 · VP of US Regulatory & FDA Rel.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2031-02-24

F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:43 UTC
DAMME LAURAVP, Clinical Affairs
GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-21-008443 · doc4.xml · derivative · entry 1

DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2031-02-24

F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 22:43 UTC
Gordon StephenChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $0.67 $0.00
Disclosure

SEC source: 0000899243-21-006942 · doc4.xml · derivative · entry 3

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,713

Underlying: Common Stock · 10,000 shares

Expires 2025-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 22:43 UTC
Gordon StephenChief Financial Officer
SaleCommon Stock 10,000 $31.33 $313,300.00
Disclosure

SEC source: 0000899243-21-006942 · doc4.xml · nonDerivative · entry 2

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $31.00 to $31.82, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 22:43 UTC
Gordon StephenChief Financial Officer
Exercise / conversionCommon Stock 10,000 $0.67 $6,700.00
Disclosure

SEC source: 0000899243-21-006942 · doc4.xml · nonDerivative · entry 1

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 09, 2021 Filed Feb 10, 2021 16:53 UTC SaleCommon Stock 786,664 $33.32 $26,208,733.82
Disclosure

SEC source: 0000899243-21-005693 · doc4.xml · nonDerivative · entry 2

ABRAMS CAPITAL MANAGEMENT, L.P. · CIK 0001358706 · 10% owner

ABRAMS CAPITAL MANAGEMENT, LLC · CIK 0001165407 · 10% owner

Abrams Capital Partners II, L.P. · CIK 0001292420 · 10% owner

ABRAMS CAPITAL, LLC · CIK 0001112443 · 10% owner

Abrams David C · CIK 0001292250 · 10% owner

Riva Capital Partners III, L.P. · CIK 0001525135 · 10% owner

Riva Capital Management III, LLC · CIK 0001775371 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 2,624,712

F5 · price: Represents the weighted average sale price of shares sold in a series of open market transactions on the transaction date at prices ranging from $33.04461 to $33.31643 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.

F2 · ownership.nature: Shares reported herein as beneficially owned by (i) Abrams Capital, LLC ("Abrams Capital") represent shares held for the account of Abrams Capital Partners II, L.P. ("ACP II") and other private investment funds for which Abrams Capital serves as general partner; and (ii) Riva Capital Management III, LLC ("RCM III") represent shares held for the account of Riva Capital Partners III, L.P. ("Riva III"), for which RCM III serves as general partner. Shares reported herein for Abrams Capital Management, L.P. (the "LP") and Abrams Capital Management, LLC (the "LLC") represent shares beneficially owned by private investment funds for which the LP serves as investment manager, including ACP II and Riva III. The LLC is the general partner of the LP. Shares reported herein for Mr. Abrams represent the above referenced shares reported for Abrams Capital, RCM III and the LLC. Mr. Abrams is the managing member of Abrams Capital, RCM III, and the LLC.

F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest in such shares, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

F6 · ownership.nature: Of the shares sold on February 9, 2021, 365,078 shares were held for the account of ACP II; 327,777 shares were held for the account of Riva III; RCM III may be deemed to beneficially own 327,777 shares; Abrams Capital may be deemed to beneficially own 432,043 shares; and all such shares may be deemed to have been beneficially owned by Mr. Abrams, the LP and the LLC.

Read SEC document
February 09, 2021 Filed Feb 10, 2021 23:59 UTC SaleCommon Stock 200 $34.18 $6,836.00
Disclosure

SEC source: 0000899243-21-005746 · doc4.xml · nonDerivative · entry 2

TOBIN JAMES R · CIK 0001190128 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By the James R. Tobin 2012 Trust

Disclosed balance after: 424,637

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 09, 2021 Filed Feb 10, 2021 23:59 UTC SaleCommon Stock 9,968 $32.80 $326,950.40
Disclosure

SEC source: 0000899243-21-005746 · doc4.xml · nonDerivative · entry 1

TOBIN JAMES R · CIK 0001190128 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By the James R. Tobin 2012 Trust

Disclosed balance after: 424,837

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.50 to $33.30 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 13:57 UTC
Sullivan John FVP of Quality & Engineering
Exercise / conversionStock Option (Right to Buy) · Derivative 8,600 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0000899243-21-005847 · doc4.xml · derivative · entry 4

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,600 shares

Expires 2023-03-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 13:57 UTC
Sullivan John FVP of Quality & Engineering
SaleCommon Stock 200 $34.18 $6,836.00
Disclosure

SEC source: 0000899243-21-005847 · doc4.xml · nonDerivative · entry 3

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,828

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 13:57 UTC
Sullivan John FVP of Quality & Engineering
SaleCommon Stock 8,400 $32.78 $275,352.00
Disclosure

SEC source: 0000899243-21-005847 · doc4.xml · nonDerivative · entry 2

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,028

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.50 to $33.41 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 13:57 UTC
Sullivan John FVP of Quality & Engineering
Exercise / conversionCommon Stock 8,600 $0.28 $2,408.00
Disclosure

SEC source: 0000899243-21-005847 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,428

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 16:53 UTC SaleCommon Stock 88,483 $26.24 $2,321,705.44
Disclosure

SEC source: 0000899243-21-005693 · doc4.xml · nonDerivative · entry 1

ABRAMS CAPITAL MANAGEMENT, L.P. · CIK 0001358706 · 10% owner

ABRAMS CAPITAL MANAGEMENT, LLC · CIK 0001165407 · 10% owner

Abrams Capital Partners II, L.P. · CIK 0001292420 · 10% owner

ABRAMS CAPITAL, LLC · CIK 0001112443 · 10% owner

Abrams David C · CIK 0001292250 · 10% owner

Riva Capital Partners III, L.P. · CIK 0001525135 · 10% owner

Riva Capital Management III, LLC · CIK 0001775371 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 3,411,376

F1 · price: Represents the weighted average sale price of shares sold in a series of open market transactions on the transaction date at prices ranging from $26.23646 to $26.2918 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.

F2 · ownership.nature: Shares reported herein as beneficially owned by (i) Abrams Capital, LLC ("Abrams Capital") represent shares held for the account of Abrams Capital Partners II, L.P. ("ACP II") and other private investment funds for which Abrams Capital serves as general partner; and (ii) Riva Capital Management III, LLC ("RCM III") represent shares held for the account of Riva Capital Partners III, L.P. ("Riva III"), for which RCM III serves as general partner. Shares reported herein for Abrams Capital Management, L.P. (the "LP") and Abrams Capital Management, LLC (the "LLC") represent shares beneficially owned by private investment funds for which the LP serves as investment manager, including ACP II and Riva III. The LLC is the general partner of the LP. Shares reported herein for Mr. Abrams represent the above referenced shares reported for Abrams Capital, RCM III and the LLC. Mr. Abrams is the managing member of Abrams Capital, RCM III, and the LLC.

F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest in such shares, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

F4 · ownership.nature: Of the shares sold on February 8, 2021, 41,063 shares were held for the account of ACP II; 36,868 shares were held for the account of Riva III; RCM III may be deemed to beneficially own 36,868 shares; Abrams Capital may be deemed to beneficially own 48,595 shares; and all such shares may be deemed to have been beneficially owned by Mr. Abrams, the LP and the LLC.

Read SEC document
February 08, 2021 Filed Feb 11, 2021 00:00 UTC
Gordon StephenChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,429 $0.00 Strike: $0.67 $0.00
Disclosure

SEC source: 0000899243-21-005748 · doc4.xml · derivative · entry 4

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,713

Underlying: Common Stock · 1,429 shares

Expires 2025-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · derivative.exercise_date: The option is fully vested.

Read SEC document
February 08, 2021 Filed Feb 11, 2021 00:00 UTC
Gordon StephenChief Financial Officer
SaleCommon Stock 1,429 $25.01 $35,739.29
Disclosure

SEC source: 0000899243-21-005748 · doc4.xml · nonDerivative · entry 3

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 08, 2021 Filed Feb 11, 2021 00:00 UTC
Gordon StephenChief Financial Officer
Exercise / conversionCommon Stock 1,429 $0.67 $957.43
Disclosure

SEC source: 0000899243-21-005748 · doc4.xml · nonDerivative · entry 2

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,429

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 08, 2021 Filed Feb 11, 2021 00:00 UTC
Gordon StephenChief Financial Officer
SaleCommon Stock 8,571 $25.01 $214,360.71
Disclosure

SEC source: 0000899243-21-005748 · doc4.xml · nonDerivative · entry 1

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 02:00 UTC
Sullivan John FVP of Quality & Engineering
Exercise / conversionStock Option (Right to Buy) · Derivative 9,617 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0000899243-21-002615 · doc4.xml · derivative · entry 3

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 9,617 shares

Expires 2021-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 02:00 UTC
Sullivan John FVP of Quality & Engineering
SaleCommon Stock 9,617 $22.12 $212,728.04
Disclosure

SEC source: 0000899243-21-002615 · doc4.xml · nonDerivative · entry 2

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,828

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $21.99 to $22.55 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 02:00 UTC
Sullivan John FVP of Quality & Engineering
Exercise / conversionCommon Stock 9,617 $0.39 $3,750.63
Disclosure

SEC source: 0000899243-21-002615 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 05, 2021 Filed Jan 14, 2021 23:56 UTC
Hassanein Waleed HDirector · President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 123,414 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0000899243-21-002088 · doc4.xml · derivative · entry 2

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 123,414 shares

Expires 2021-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is fully vested.

Read SEC document
January 05, 2021 Filed Jan 14, 2021 23:56 UTC
Hassanein Waleed HDirector · President & CEO
Exercise / conversionCommon Stock 123,414 $0.39 $48,131.46
Disclosure

SEC source: 0000899243-21-002088 · doc4.xml · nonDerivative · entry 1

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 23:04 UTC
Gordon StephenChief Financial Officer
SaleCommon Stock 1,184 $20.00 $23,680.00
Disclosure

SEC source: 0000899243-21-000439 · doc4.xml · nonDerivative · entry 2

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,371

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 22:57 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $19.90 $0.00
Disclosure

SEC source: 0000899243-21-000436 · doc4.xml · derivative · entry 1

RAINES MERILEE · CIK 0001023869 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-01-01

F1 · derivative.exercise_date: The option vests as to one-third of the shares subject to the option on the first anniversary of the date of grant and in equal monthly installments as to the remainder of the shares for two years thereafter.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 23:04 UTC
Gordon StephenChief Financial Officer
SaleCommon Stock 8,816 $20.00 $176,320.00
Disclosure

SEC source: 0000899243-21-000439 · doc4.xml · nonDerivative · entry 1

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,755

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 21, 2020 Filed Dec 22, 2020 21:19 UTC
Sullivan John FVP of Quality & Engineering
SaleCommon Stock 1,000 $17.99 $17,990.00
Disclosure

SEC source: 0000899243-20-034833 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,828

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.66 to $18.35 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 16, 2020 Filed Dec 17, 2020 22:57 UTC
Sullivan John FVP of Quality & Engineering
Exercise / conversionStock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0000899243-20-034318 · doc4.xml · derivative · entry 5

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,617

Underlying: Common Stock · 1,000 shares

Expires 2021-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
December 16, 2020 Filed Dec 17, 2020 22:57 UTC
Sullivan John FVP of Quality & Engineering
Exercise / conversionCommon Stock 1,000 $0.39 $390.00
Disclosure

SEC source: 0000899243-20-034318 · doc4.xml · nonDerivative · entry 3

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2020 Filed Dec 17, 2020 22:57 UTC
Sullivan John FVP of Quality & Engineering
Exercise / conversionStock Option (Right to Buy) · Derivative 3,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0000899243-20-034318 · doc4.xml · derivative · entry 4

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,617

Underlying: Common Stock · 3,000 shares

Expires 2021-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
December 15, 2020 Filed Dec 17, 2020 22:57 UTC
Sullivan John FVP of Quality & Engineering
SaleCommon Stock 3,000 $16.63 $49,890.00
Disclosure

SEC source: 0000899243-20-034318 · doc4.xml · nonDerivative · entry 2

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,828

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.50 to $16.81 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2020 Filed Dec 17, 2020 22:57 UTC
Sullivan John FVP of Quality & Engineering
Exercise / conversionCommon Stock 3,000 $0.39 $1,170.00
Disclosure

SEC source: 0000899243-20-034318 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 11, 2020 Filed Dec 14, 2020 21:53 UTC
Provost MiriamVP of US Regulatory & FDA Rel.
Exercise / conversionStock Option (Right to Buy) · Derivative 4,600 $0.00 Strike: $3.22 $0.00
Disclosure

SEC source: 0000899243-20-033750 · doc4.xml · derivative · entry 2

Provost Miriam · CIK 0001773663 · VP of US Regulatory & FDA Rel.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,971

Underlying: Common Stock · 4,600 shares

Expires 2028-04-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and will vest at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date.

Read SEC document
December 11, 2020 Filed Dec 14, 2020 21:53 UTC
Provost MiriamVP of US Regulatory & FDA Rel.
Exercise / conversionCommon Stock 4,600 $3.22 $14,812.00
Disclosure

SEC source: 0000899243-20-033750 · doc4.xml · nonDerivative · entry 1

Provost Miriam · CIK 0001773663 · VP of US Regulatory & FDA Rel.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2020 Filed Sep 3, 2020 22:41 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0000899243-20-024190 · doc4.xml · derivative · entry 3

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2021-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
September 01, 2020 Filed Sep 3, 2020 22:41 UTC
Carey John FVP of Operations
SaleCommon Stock 2,000 $17.59 $35,180.00
Disclosure

SEC source: 0000899243-20-024190 · doc4.xml · nonDerivative · entry 2

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,200

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.23 to $17.90 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 01, 2020 Filed Sep 3, 2020 22:41 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 2,000 $0.39 $780.00
Disclosure

SEC source: 0000899243-20-024190 · doc4.xml · nonDerivative · entry 1

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
August 03, 2020 Filed Aug 6, 2020 00:08 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0000899243-20-021569 · doc4.xml · derivative · entry 4

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,331

Underlying: Common Stock · 2,000 shares

Expires 2027-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The option vests as a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017.

Read SEC document
August 03, 2020 Filed Aug 6, 2020 00:08 UTC
Carey John FVP of Operations
SaleCommon Stock 142 $18.96 $2,692.32
Disclosure

SEC source: 0000899243-20-021569 · doc4.xml · nonDerivative · entry 3

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,200

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $18.90 to $19.02 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 03, 2020 Filed Aug 6, 2020 00:08 UTC
Carey John FVP of Operations
SaleCommon Stock 1,858 $18.58 $34,521.64
Disclosure

SEC source: 0000899243-20-021569 · doc4.xml · nonDerivative · entry 2

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,342

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.90 to $18.88 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 03, 2020 Filed Aug 6, 2020 00:08 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 2,000 $2.21 $4,420.00
Disclosure

SEC source: 0000899243-20-021569 · doc4.xml · nonDerivative · entry 1

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 23:42 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 1,106 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0000899243-20-018365 · doc4.xml · derivative · entry 6

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,331

Underlying: Common Stock · 1,106 shares

Expires 2027-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F5 · derivative.exercise_date: The option vests as a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 23:42 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 894 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0000899243-20-018365 · doc4.xml · derivative · entry 5

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 894 shares

Expires 2021-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The option is fully vested.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 23:42 UTC
Carey John FVP of Operations
SaleCommon Stock 600 $17.92 $10,752.00
Disclosure

SEC source: 0000899243-20-018365 · doc4.xml · nonDerivative · entry 4

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,200

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.59 to $18.27 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.